NCT02678286View on ClinicalTrials.gov

Evaluation of N1539 Following Abdominoplasty Surgery

PHASE3CompletedINTERVENTIONAL

Enrollment

219

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

November 30, 2016

Conditions

Pain, Post-operative

Interventions

DRUG

N1539

DRUG

Intravenous Placebo

Trial Locations (4)

Unknown

Lotus Clinical Research, LLC, Pasadena

HD Research, Bellaire

Research Concepts, Bellaire

Endeavor Clinical Trials, San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Baudax Bio

INDUSTRY